71 related articles for article (PubMed ID: 16850145)
1. Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection.
Hatano E; Ikai I; Higashi T; Teramukai S; Torizuka T; Saga T; Fujii H; Shimahara Y
World J Surg; 2006 Sep; 30(9):1736-41. PubMed ID: 16850145
[TBL] [Abstract][Full Text] [Related]
2. Predicting Overall Survival with Deep Learning from 18F-FDG PET-CT Images in Patients with Hepatocellular Carcinoma before Liver Transplantation.
Lai YC; Wu KC; Chang CJ; Chen YJ; Wang KP; Jeng LB; Kao CH
Diagnostics (Basel); 2023 Mar; 13(5):. PubMed ID: 36900125
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of
Park JC; Park JG; Jung GS; Kang H; Jun S
Taehan Yongsang Uihakhoe Chi; 2020 Nov; 81(6):1424-1435. PubMed ID: 36237710
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment Metabolic Parameters Measured by
Wang G; Zhang W; Chen J; Luan X; Wang Z; Wang Y; Xu X; Yao S; Guan Z; Tian J; Lu S; Xu B; Ma G
Front Oncol; 2022; 12():884372. PubMed ID: 35719917
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment Positron Emission Tomography with 18F-Fluorodeoxyglucose May Be a Useful New Predictor of Early Progressive Disease following Atezolizumab plus Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma.
Kawamura Y; Kobayashi M; Shindoh J; Matsumura M; Okubo S; Muraishi N; Fujiyama S; Hosaka T; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ikeda K; Arase Y; Hashimoto M; Kumada H
Oncology; 2022; 100(6):320-330. PubMed ID: 35231914
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of anatomical resection on long-term outcomes after hepatectomy for primary solitary hepatocellular carcinoma with or without preoperative positron emission tomography positivity.
Cho CW; Kim JM; Lee BH; Lee DS; Yun SS; Choi GS; Joh JW
Ann Transl Med; 2020 Nov; 8(21):1377. PubMed ID: 33313122
[TBL] [Abstract][Full Text] [Related]
7. Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment.
Yamashige D; Kawamura Y; Kobayashi M; Shindoh J; Kobayashi Y; Okubo S; Muraishi N; Kajiwara A; Iritani S; Fujiyama S; Hosaka T; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ikeda K; Arase Y; Hashimoto M; Kumada H
Oncology; 2021; 99(3):169-176. PubMed ID: 33207358
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of
Ida Y; Tamai H; Shingaki N; Shimizu R; Maeshima S; Maekita T; Iguchi M; Terada M; Kitano M
Cancer Imaging; 2020 Oct; 20(1):74. PubMed ID: 33076990
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Ramucirumab in Patients with Unresectable Hepatocellular Carcinoma with Progression after Treatment with Lenvatinib.
Kasuya K; Kawamura Y; Kobayashi M; Shindoh J; Kobayashi Y; Kajiwara A; Iritani S; Fujiyama S; Hosaka T; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ikeda K; Arase Y; Eguchi Y; Hashimoto M; Kumada H
Intern Med; 2021 Feb; 60(3):345-351. PubMed ID: 32963154
[TBL] [Abstract][Full Text] [Related]
10.
Hu XG; Shen XY; Nan JN; Kim IG; Yoon JK; Hong SY; Kim MN; Kim BW; Wang HJ
Ann Surg Treat Res; 2020 Jul; 99(1):8-17. PubMed ID: 32676477
[TBL] [Abstract][Full Text] [Related]
11.
Kawamura Y; Kobayashi M; Shindoh J; Kobayashi Y; Kasuya K; Sano T; Fujiyama S; Hosaka T; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Ikeda K; Arase Y; Hashimoto M; Kumada H
Liver Cancer; 2020 Jan; 9(1):84-92. PubMed ID: 32071912
[TBL] [Abstract][Full Text] [Related]
12. Emerging role of
Lee SM; Kim HS; Lee S; Lee JW
World J Gastroenterol; 2019 Mar; 25(11):1289-1306. PubMed ID: 30918424
[TBL] [Abstract][Full Text] [Related]
13.
Kornberg A; Friess H
Therap Adv Gastroenterol; 2019; 12():1756284819836205. PubMed ID: 30915167
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for advanced hepatocellular carcinoma: how far can we go?
Suh KS; Lee HW
Hepat Oncol; 2015 Jan; 2(1):19-28. PubMed ID: 30190984
[TBL] [Abstract][Full Text] [Related]
15.
Kornberg A; Schernhammer M; Friess H
J Clin Transl Hepatol; 2017 Sep; 5(3):224-234. PubMed ID: 28936404
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of pre-treatment F-18-FDG PET-CT in patients with hepatocellular carcinoma undergoing radioembolization.
Abuodeh Y; Naghavi AO; Ahmed KA; Venkat PS; Kim Y; Kis B; Choi J; Biebel B; Sweeney J; Anaya DA; Kim R; Malafa M; Frakes JM; Hoffe SE; El-Haddad G
World J Gastroenterol; 2016 Dec; 22(47):10406-10414. PubMed ID: 28058021
[TBL] [Abstract][Full Text] [Related]
17. Proposal of new expanded selection criteria using total tumor size and (18)F-fluorodeoxyglucose - positron emission tomography/computed tomography for living donor liver transplantation in patients with hepatocellular carcinoma: The National Cancer Center Korea criteria.
Lee SD; Lee B; Kim SH; Joo J; Kim SK; Kim YK; Park SJ
World J Transplant; 2016 Jun; 6(2):411-22. PubMed ID: 27358787
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review.
Xu DW; Wan P; Xia Q
World J Gastroenterol; 2016 Mar; 22(12):3325-34. PubMed ID: 27022214
[TBL] [Abstract][Full Text] [Related]
19. A non-smooth tumor margin on preoperative imaging predicts microvascular invasion of hepatocellular carcinoma.
Wu TH; Hatano E; Yamanaka K; Seo S; Taura K; Yasuchika K; Fujimoto Y; Nitta T; Mizumoto M; Mori A; Okajima H; Kaido T; Uemoto S
Surg Today; 2016 Nov; 46(11):1275-81. PubMed ID: 26983710
[TBL] [Abstract][Full Text] [Related]
20. Appropriateness criteria of FDG PET/CT in oncology.
Agrawal A; Rangarajan V
Indian J Radiol Imaging; 2015; 25(2):88-101. PubMed ID: 25969632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
